Executive Leadership

President
PhD, HCLD (ABB)

Dr. Altrich is the President of Eurofins Viracor. She held the previous role of Chief Scientific Officer, VP and Clinical Laboratory Director.  In her experience at IBT, Dr. Altrich was responsible for new test development in the area of cellular function testing for allergy and autoimmune diseases as well as serving as the Assistant Lab Director for IBT's menu of immunodiagnostic tests. Dr. Altrich joined IBT in 2006 as a Senior Scientist. Prior to joining IBT, Dr. Altrich held an appointment at the University of Virginia in Charlottesville where she specialized in molecular and cellular immunology. Dr. Altrich received her PhD in pathology and microbiology from the University of Nebraska Medical Center where her research focused on tumor immunology.

Clinical Laboratory Director
PhD, BCLD (ABB)

Dr. Neil has served as the Clinical Laboratory Director of Eurofins Viracor since the beginning of 2021. He maintains oversight of laboratory operations and compliance and serves as a technical expert for diagnostic testing. His previous role was as Vice President of Infectious Disease Operations at AEL starting in 2013. His clinical laboratory expertise is in infectious disease diagnostics including molecular diagnostics, immunoserology and microbiology. Dr. Neil was an APHL-CDC Emerging and Infectious Disease Fellow and maintained roles in public health laboratories for several years. Dr. Neil received his PhD in Microbiology from the University of Iowa where his research focused on Neisseria meningitidis pathogenesis.

Vice President of Sales and Marketing

Rob Horel rejoined Eurofins Viracor on May 17, 2021 as Vice President of Sales and Marketing.  Rob has more than two decades of experience in commercial leadership. He displays a deep passion for Improving Patient Lives and has an outstanding record of sales and marketing excellence in laboratory services and medical digital platforms. Most recently, Rob was Vice President of Sales for North America at SOPHiA Genetics – a Swiss AI company focused on democratizing data driven medicine. Rob started his leadership career as a Commissioned Officer for the United States Navy and has a BS in Mechanical Engineering from the US Naval Academy.

Vice President, Laboratory Operations
Eurofins U.S. Clinical Diagnostics

Matthew Schuman is the Vice President of Laboratory Operations at Eurofins Viracor since early 2022. He is responsible for the day to day operations of the clinical diagnostics laboratory. Mr. Schuman has held executive leadership roles in the laboratory industry throughout his career including hospitals, large reference laboratories, and developed two separate “start up” full service veterinary laboratories. His most recent position was the Laboratory Director at St. Joseph Medical Center in Kansas City, MO. He is certified as a Black Belt in LEAN Six Sigma, holds a Bachelor of Science in Medical Technology from the University of Nebraska Medical Center, and a Bachelor’s of Science from the University of Nebraska – Lincoln. He completed his MBA at Benedictine College in Atchison, KS.

Vice President, Research & Development
PhD, HCLD/TS/CC (ABB) 

Steven Kleiboeker, PhD, Vice President of Research and Development, is responsible for the scientific direction and oversight of the Company's research and development programs, as well as the BioPharma and Clinical Trial Biomarker Services research businesses. Dr. Kleiboeker is board certified as a high-complexity laboratory director, technical supervisor and clinical consultant by the American Board of Bioanalysis. Dr. Kleiboeker has served as both principal investigator and co-investigator on numerous government-funded research grants (NIH, USDA). Dr. Kleiboeker received his PhD and DVM from the University of Missouri.

Vice President, Integrated Programs

Janet Anthony joined Eurofins Viracor in 2019, having over 20 years of experience in the laboratory industry.  Ms. Anthony has held senior management positions at Sonic Healthcare USA, Eurofins-TestAmerica, The Laboratory Choice (founding member), Quest Diagnostics, Unilab and Dynacare Laboratories. 

Prior to her position as VP of Integrated Programs, Janet served as the Director of Training and Development for the commercial team and the lab associates at Viracor-Eurofins.  She is still actively involved in elevating the organization through employee professional development. 

Her experience in training, project management, mergers and acquisitions and contracting lends a unique perspective for cross-functional collaboration to strategically implement programs that align with corporate objectives. 

Ms. Anthony received her Bachelor of Science degree and her Master of Social Science degree from the University of Oklahoma. 

Director of Human Resources

With over 25 years of experience in Human Resources, Robert Braun brings an extensive background in executive leadership and global operations to Viracor. Prior to joining Viracor, Robert spent three decades in the manufacturing sector, where he held various senior roles, gaining invaluable insights into operational excellence and strategic leadership.

With 15 years of experience as an executive leader, and over 10 of those as a global executive, Rob has been instrumental in driving organizational success through innovative HR strategies and fostering a culture of excellence and collaboration. 

Robert holds a BS degree in Organizational Development, which underscores his commitment to integrating academic insights with practical expertise to optimize organizational performance and empower teams. Known for his strategic vision and transformative leadership style, Robert is dedicated to advancing Viracor's mission of improving lives, one test at a time.

Director of Finance

Jeffrey Enright brings extensive financial leadership experience to Eurofins Viracor, spanning public, venture-backed, and family-owned businesses. Specializing in developing and executing financial strategies that drive organizational growth and operational efficiency, Jeffrey provides valuable insights to executive teams.

As Finance Director, Jeffrey manages budgeting, long-range financial planning, forecasting, project-based and sales performance analysis, commission management, and M&A support. He excels in crafting detailed analytical reports and presentations, leveraging deep operational expertise to anticipate industry trends and advance strategic initiatives. He effectively communicates complex financial concepts across all organizational levels and collaborates seamlessly with cross-functional teams and external stakeholders to ensure cohesive financial strategy alignment.

Jeffrey holds an MBA and a BS in Administration and Accounting from the University of Kansas, demonstrating his commitment to exemplary financial leadership and operational excellence at Eurofins Viracor.

Director of Laboratory Operations
MBA, MT (ASCP)

Phouvieng Saycocie is the Director of Laboratory Operations for Viracor Eurofins.  She provides overall direction and leadership for the clinical laboratory and is responsible for ensuring quality and regulatory compliance in all aspects of the laboratory operation. She coordinates activities for test menu expansion and transfer of new technologies into the laboratory.  Ms. Saycocie has over 20+ years working in the lab industry having previously worked at Quest Diagnostics.  She served as a Clinical Lab Scientist and Laboratory Supervisor at Quest Diagnostics.  She joined Viracor as the Laboratory Manager for Infectious Disease then led  the IT Business Analysts as the Assistant Director of Lab Operations.   Ms. Saycodie graduated from the University of Kansas with a BS in Medical Technology and from Baker University with a Master of Business Administration.

Director of Research & Development, Bioinformatics

Rohita Sinha joined Viracor Eurofins in 2018 as a Senior Scientist, with the primary focus on developing novel computational protocols for a range of diagnostic assays to detect and monitor infections disease and solid organ transplant rejection. Prior to joining Viracor Eurofins, Dr. Sinha was a Research Asst. Professor at Univ. of Nebraska, Lincoln where he extensively worked on application of next-generation sequencing to understand the complexity of the gut microbiota. Dr. Sinha is co-founder of a Bioinformatics startup (Metagenome Analytics, LLC), with the core business of developing computational methods to detect and subtype food pathogens. He has received his PhD (Bioinformatics) from the University of Kansas, Lawrence in 2011.

Director of Research and Development, Biopharma Services
PhD 

Prior to his appointment in R&D, Dr. Wissel has been a Senior Scientist directing the development of fungal diagnostic assays at Viracor Eurofins since 2006. Prior to joining Viracor Eurofins, he was a Post-Doctoral Fellow in the Department of Microbiology, Molecular Genetics and Immunology  at the University of Kansas Medical Center where he conducted research into the molecular mechanisms of bacterial cell division.  He received his PhD in Microbiology from the University of Iowa College of Medicine.

Director of Research & Development, Oncology Diagnostics
MSc, PhD

Dr. Karina Eterovic is the R&D Director, Oncology Diagnostics, responsible for leading the development of oncology clinical diagnostic solutions for the Eurofins U.S. Clinical Diagnostics group.  Dr. Eterovic joins us from MD Anderson Cancer Center, where she was the Associate Professor and Director of the Cancer Genomics Laboratory, as well as a driving force in the implementation of precision medicine at the prestigious institute — establishing a genomics laboratory for NGS research, and enabling the discovery and identification of new biomarkers for personalized cancer care.  Dr. Eterovic has authored many publications in oncology journals, and holds both her PhD in Biochemistry and Molecular Biology, and Masters in Biochemistry from the University of Sao Paulo, Medical School, in Brazil.